Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Curran

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
Ultrasound in Medicine & Biology|September 3, 2013
Automated skin segmentation in ultrasonic evaluation of skin toxicity in breast cancer radiotherapyYi Gao, Allen Tannenbaum, Hao Chen, et al.
Cancer|April 21, 2012
Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literatureWilliam A Hall, Arif N Ali, Norleena Gullett, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiformeJudith M Ford, Wendy Seiferheld, Jeffrey R Alger, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology GroupArnab Chakravarti, Wendy Seiferheld, Xiaoyu Tu, et al.
Medical Physics|February 25, 2009
Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapyGreg Bednarz, Mitchell Machtay, Maria Werner-Wasik, et al.
Journal of Applied Clinical Medical Physics|November 15, 2012
Six degrees of freedom CBCT-based positioning for intracranial targets treated with frameless stereotactic radiosurgeryAnees Dhabaan, Eduard Schreibmann, Arsalan Siddiqi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2012
Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local controlRoshan Prabhu, Hui-Kuo Shu, Constantinos Hadjipanayis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411Christopher H Crane, Kathryn Winter, William F Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402Gregory Cairncross, Meihua Wang, Edward Shaw, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
Ultrasound in Medicine & Biology|September 3, 2013
Automated skin segmentation in ultrasonic evaluation of skin toxicity in breast cancer radiotherapyYi Gao, Allen Tannenbaum, Hao Chen, et al.
Cancer|April 21, 2012
Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literatureWilliam A Hall, Arif N Ali, Norleena Gullett, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiformeJudith M Ford, Wendy Seiferheld, Jeffrey R Alger, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology GroupArnab Chakravarti, Wendy Seiferheld, Xiaoyu Tu, et al.
Medical Physics|February 25, 2009
Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapyGreg Bednarz, Mitchell Machtay, Maria Werner-Wasik, et al.
Journal of Applied Clinical Medical Physics|November 15, 2012
Six degrees of freedom CBCT-based positioning for intracranial targets treated with frameless stereotactic radiosurgeryAnees Dhabaan, Eduard Schreibmann, Arsalan Siddiqi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2012
Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local controlRoshan Prabhu, Hui-Kuo Shu, Constantinos Hadjipanayis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411Christopher H Crane, Kathryn Winter, William F Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402Gregory Cairncross, Meihua Wang, Edward Shaw, et al.
Pageof 4